Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Kapil Dhingra

Premium

Exosome Diagnostics, a developer of biofluid-based molecular diagnostics for cancer, announced that Kapil Dhingra has joined the company's board of directors.

Dhingra is the managing member of the healthcare consulting firm KAPital Consulting, which provides oncology-related strategic advice to biopharmaceutical companies. Also, from 1999 to 2008, he held various positions at Hoffmann-La Roche, including VP of the company's oncology disease biology leadership team and the head of oncology clinical development.

Filed under

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.